Method for predicting chemosensitivity of anti-cancer drugs

Details Method for predicting chemosensitivity of anti-cancer drugs Method for predicting chemosensitivity of anti-cancer drugs

1989-02-07

1990-06-26

Rosen, Sam

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving viable micro-organism

435 1, 4352402, 43524021, C12Q 102

Patent

active

049371827

ABSTRACT:
An assay for determining the sensitivity of an individual patient tumor to particular chemotherapeutic drugs relies on growth of the neoplastic tumor cells in a mass culture. The mass culture medium provides metabolites essential for the growth of the cells, even in the presence of the particular drug being tested, which is usually an anti-metabolic drug. The mass culture of cells is exposed to a labelled analog of the drug, and the uptake of the labelled drug analog determined. By comparing the amount of the drug uptake by the neoplastic cells with that of the corresponding normal cells, drug sensitivity may be assessed. The method is particularly useful with fluorescently-labelled drugs where the uptake may be assessed by use of a fluorescence activated cell sorter.

REFERENCES:
patent: 4559299 (1985-12-01), Rotman
patent: 4808532 (1989-02-01), Stampfer

Affiliated with

Also associated with

Rating

Method for predicting chemosensitivity of anti-cancer drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for predicting chemosensitivity of anti-cancer drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting chemosensitivity of anti-cancer drugs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1125389